Norway's decision to sequence the 25,000 Norwegians diagnosed with cancer each year will require the country to build specialized computing infrastructure to cope with the enormous influx of new data. The three-year pilot phase of the project will involve the Norwegian Cancer Genomics Consortium sequencing the genomes of tumor samples from 1,000 patients and examining 3,000 tumor biopsies to analyze the mutations and their impact on treatment. In the second phase, the computing infrastructure, clinics and laboratories will be built to cope with the data from newly diagnosed patients. Article